RxDoctor Payments DataLook up a doctor →

Jonathan Lee

Family · Antioch, TNNPI 1235419904

Payments from drug & device makers

$32,273in general payments, 2019–2025

Across 1,415 payments — averaging $22.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$6K
  • AstraZeneca$2K
  • Amgen$2K
  • AbbVie$2K
  • Bayer$2K
  • Lilly USA, LLC$1K
  • plus $17K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk248$5,575
AstraZeneca69$2,289
Amgen(2 entities)88$2,285
AbbVie112$2,030
Bayer50$1,982
Lilly USA, LLC86$1,317
Otsuka America Pharmaceutical, Inc.53$1,120
Pfizer62$1,046
GSK49$987
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)24$891
Boehringer Ingelheim57$881
Biohaven Pharmaceutical Holding Company Ltd.20$852
Exact Sciences24$690
Novartis26$654
Astellas Pharma US Inc31$642
Xeris Pharmaceuticals, Inc.28$583
Axsome Therapeutics, Inc.17$503
Merck32$460
Insulet Corporation19$453
Takeda Pharmaceuticals U.S.A., Inc.30$450
Biohaven Pharmaceuticals, Inc.13$439
BETA Bionics, Inc.6$430
Sanofi-aventis U.S. LLC30$396
Esperion Therapeutics, Inc.20$394
Gilead23$388
Johnson & Johnson16$387
Zealand Pharma US, Inc.8$383
Shield Therapeutics Inc13$324
Cequr Corporation1$279
Upsher-smith Laboratories LLC22$274
Eisai Inc.11$261
Teva Pharmaceuticals USA, Inc.12$254
Sumitomo Pharma America, Inc.15$250
Lundbeck LLC8$242
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$229
Dexcom, Inc.10$206
Viiv Healthcare Company6$196
Phathom Pharmaceuticals, Inc.5$180
Mannkind Corporation5$125
Amarin Pharma, Inc.8$123
Dynavax Technologies Corporation7$110
Arbor Pharmaceuticals, Inc.7$106
Optinose US, Inc.3$76
Edwards Lifesciences3$76
Radius Health, Inc.4$70
Ascensia Diabetes Care US Inc.2$44
Stryker1$42
Impel Pharmaceuticals Inc.2$41
Azurity Pharmaceuticals, Inc.2$35
Kowa Pharmaceuticals America, Inc.2$31
Nevro Corp.2$28
Phadia US Inc.2$26
Currax Pharmaceuticals LLC1$25
Antares Pharma, Inc.1$19
Amphastar Pharmaceuticals, Inc.1$18
Supernus Pharmaceuticals, Inc.1$17
Corcept Therapeutics1$16
Sunovion Pharmaceuticals Inc.1$16
IBSA Pharma Inc.1$16
Daiichi Sankyo Inc.1$15

How this compares

$32,273 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee →

Medicare billing

Part B allowed, 2024
$19,217
Medicare patients
57
Services billed
826

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Antioch

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →